Loss of progesterone receptor through epigenetic regulation is associated with poor prognosis in solid tumors

Background: Hormonal therapy using progestins, acting through the progesterone receptor (PR), is a well-established method to treat uterine endometrial hyperplasia and carcinoma. Recent population studies indicate that progestin exposure significantly reduces the incidence of ovarian, pancreatic and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Li, Yiyang, Huang, Cheng, Kavlashvili, Tamar, Fronk, Abby, Zhang, Yuping, Wei, Yang, Dai, Donghai, Devor, Eric J, Meng, Xiangbing, Thiel, Kristina W, Leslie, Kimberly K, Yang, Shujie
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7339273/
https://ncbi.nlm.nih.gov/pubmed/32642294
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars